FDA News in Review: September 2008

fda.sp.png

Today we're kicking off our first installment of "FDA News in Review," where each month we'll take a look at the agency's latest decision, approvals, warnings and recalls. We hope this feature will help you keep up on FDA trends--and catch up on stories you may have missed. One of the biggest stories out of the FDA this month was the agency's major hiring push, which will result many chemists, biologists and microbiologists being added to the FDA's ranks. Drug safety was also in the spotlight in September, as the agency announced that it will now release a quarterly list of drugs under investigation due to adverse events. Feature

Suggested Articles

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.

After Merck and Bayer's vericiguat scored in a heart failure trial, you'd expect potential rivals to brace themselves. Not so for Novartis'…